Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Pathogen inactivation: the definitive safeguard for the blood supply.

Bryant BJ, Klein HG.

Arch Pathol Lab Med. 2007 May;131(5):719-33. Review.

PMID:
17488157
2.

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.

Allain JP, Bianco C, Blajchman MA, Brecher ME, Busch M, Leiby D, Lin L, Stramer S.

Transfus Med Rev. 2005 Apr;19(2):110-26. Review.

PMID:
15852240
3.

Pathogen inactivation technology: cleansing the blood supply.

Klein HG.

J Intern Med. 2005 Mar;257(3):224-37. Review.

4.

Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections.

McCullough J.

Am J Clin Pathol. 2007 Dec;128(6):945-55. Review.

5.

Hemophilia therapy and blood-borne pathogen risk.

Knight R, Stanley S, Wong M, Dolan G.

Semin Thromb Hemost. 2006 Jun;32 Suppl 2:3-9. Review.

PMID:
16804829
6.

Transfusion-transmissible infections.

Vrielink H, Reesink HW.

Curr Opin Hematol. 1998 Nov;5(6):396-405. Review.

PMID:
9814646
7.

Inactivation of infectious pathogens in labile blood components: meeting the challenge.

Corash L.

Transfus Clin Biol. 2001 Jun;8(3):138-45. Review.

PMID:
11499954
8.

Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy.

Downes KA, Yomtovian R.

Clin Lab Med. 2002 Jun;22(2):475-90. Review.

PMID:
12134472
9.

Emerging infectious diseases that threaten the blood supply.

Alter HJ, Stramer SL, Dodd RY.

Semin Hematol. 2007 Jan;44(1):32-41. Review.

PMID:
17198845
10.

Alternative strategies in assuring blood safety: An overview.

Epstein JS.

Biologicals. 2010 Jan;38(1):31-5. doi: 10.1016/j.biologicals.2009.10.009. Review.

PMID:
20110174
11.

Surveillance for bloodborne infections.

Chamberland ME.

Thromb Haemost. 1999 Aug;82(2):494-9. Review.

PMID:
10605741
12.

Consideration in hemophilia therapy selection.

Pipe S.

Semin Hematol. 2006 Apr;43(2 Suppl 3):S23-7. Review.

PMID:
16631824
13.

Hepatitis B and blood safety.

Kitchen A.

Vaccine. 1998 Nov;16 Suppl:S34-7. Review.

PMID:
9915031
14.

Infectious disease testing for blood transfusions.

[No authors listed]

NIH Consens Statement. 1995 Jan 9-11;13(1):1-27. Review.

PMID:
7581534
15.

[Update on infectious risks associated with blood products].

Traineau R, Elghouzzi MH, Bierling P.

Rev Prat. 2009 Jan 20;59(1):86-9. Review. French.

PMID:
19253889
16.
17.

[Blood transfusion: control of infectious risks].

Laperche S, Lefrère JJ, Morel P, Pouchol E, Pozzetto B.

Presse Med. 2015 Feb;44(2):189-99. doi: 10.1016/j.lpm.2014.06.034. Review. French.

PMID:
25547992
18.

Safe blood transfusion practices.

Bharucha ZS.

Indian J Pediatr. 2001 Feb;68(2):127-31. Review.

PMID:
11284180
19.

Overview: diagnostic tests for viral infections transmitted by blood.

Holland PV.

Nucl Med Biol. 1994 Apr;21(3):407-17. Review.

PMID:
9234305
20.

Pathogen inactivation techniques.

Pelletier JP, Transue S, Snyder EL.

Best Pract Res Clin Haematol. 2006;19(1):205-42. Review.

PMID:
16377551
Items per page

Supplemental Content

Support Center